PB2115: TRIAL IN PROGRESS: A RANDOMIZED PHASE II STUDY OF MB-CART2019.1 COMPARED TO STANDARD OF CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION. (23rd June 2022) - Borchmann, P.; Vandenberghe, P.; Urbano, A.; Haioun, C.; Lemonnier, F.; Griškevicius, L.; Maury, S.; Holtkamp, S.; Friedrichs, B.; Zadoyan, G.; Hanssens, L.; Brillant, C.; et al.